These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 6688951)

  • 1. Mycoplasma gallisepticum (MG)--laboratory and field studies evaluating the safety and efficacy of an inactivated MG bacterin.
    Hildebrand DG; Page DE; Berg JR
    Avian Dis; 1983; 27(3):792-802. PubMed ID: 6688951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of experimental inactivated mycoplasma gallisepticum oil-emulsion bacterin in egg-layer chickens.
    Yoder HW; Hopkins SR
    Avian Dis; 1985; 29(2):322-34. PubMed ID: 2992434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bacterins and vaccines for the control of Mycoplasma gallisepticum.
    Kleven SH; Glisson JR; Lin MY; Talkington FD
    Isr J Med Sci; 1984 Oct; 20(10):989-91. PubMed ID: 6548986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mycoplasma gallisepticum vaccination: effects on egg transmission and egg production.
    Glisson JR; Kleven SH
    Avian Dis; 1984; 28(2):406-15. PubMed ID: 6743175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Mycoplasma gallisepticum bacterin on egg-transmission and egg production.
    Sasipreeyajan J; Halvorson DA; Newman JA
    Avian Dis; 1987; 31(4):776-81. PubMed ID: 3442529
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mycoplasma gallisepticum vaccination: further studies on egg transmission and egg production.
    Glisson JR; Kleven SH
    Avian Dis; 1985; 29(2):408-15. PubMed ID: 4026735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of a vaccine against Mycoplasma gallisepticum in commercial broilers.
    Rodriguez R; Kleven SH
    Avian Dis; 1980; 24(4):879-89. PubMed ID: 7271643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenic potency of oil-emulsified Mycoplasma gallisepticum bacterins.
    Panigraphy B; Grumbles LC; Hall CF
    Avian Dis; 1981; 25(4):821-6. PubMed ID: 7337609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of a Mycoplasma gallisepticum strain exhibiting reduced virulence for prevention and control of poultry mycoplasmosis.
    Evans RD; Hafez YS
    Avian Dis; 1992; 36(2):197-201. PubMed ID: 1385698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparative study of Mycoplasma gallisepticum vaccines in young chickens.
    Abd-el-Motelib TY; Kleven SH
    Avian Dis; 1993; 37(4):981-7. PubMed ID: 8141758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunity induced with an aluminum hydroxide-adsorbed Mycoplasma gallisepticum bacterin in chickens.
    Yagihashi T; Nunoya T; Tajima M
    Avian Dis; 1987; 31(1):149-55. PubMed ID: 3579785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mycoplasma gallisepticum vaccination-challenge: an egg-production model.
    Evans RD; Hafez YS; Orthel FW
    Avian Dis; 1992; 36(4):956-63. PubMed ID: 1485879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccination with F-strain Mycoplasma gallisepticum to reduce production losses in layer chickens.
    Carpenter TE; Mallinson ET; Miller KF; Gentry RF; Schwartz LD
    Avian Dis; 1981; 25(2):404-9. PubMed ID: 7259680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of inactivated Mycoplasma gallisepticum oil-emulsion bacterins for protection against airsacculitis in broilers.
    Yoder HW; Hopkins SR; Mitchell BW
    Avian Dis; 1984; 28(1):224-34. PubMed ID: 6721795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tracheal populations of Mycoplasma gallisepticum after challenge of bacterin-vaccinated chickens.
    Kleven SH
    Avian Dis; 1985; 29(4):1012-7. PubMed ID: 3833213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Poor systemic antibody response after vaccination of commercial broiler breeders with Mycoplasma gallisepticum vaccine ts-11 not associated with susceptibility to challenge.
    Noormohammadi AH; Jones JE; Underwood G; Whithear KG
    Avian Dis; 2002; 46(3):623-8. PubMed ID: 12243526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of commercial Mycoplasma gallisepticum bacterin (MG-Bac) in preventing air-sac lesions in chickens.
    Karaca K; Lam KM
    Avian Dis; 1987; 31(1):202-3. PubMed ID: 3579788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of immunity induced with a Mycoplasma gallisepticum bacterin between high- and low-responder lines of chickens.
    Yagihashi T; Nunoya T; Sannai S; Tajima M
    Avian Dis; 1992; 36(1):125-33. PubMed ID: 1567299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Observations on commercial layers vaccinated with Mycoplasma gallisepticum (MG) bacterin on a multiple-age site endemically infected with MG.
    Khan MI; McMartin DA; Yamamoto R; Ortmayer HB
    Avian Dis; 1986; 30(2):309-12. PubMed ID: 3729876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utilization of temperature-sensitive mutants of Mycoplasma gallisepticum to prevent air sac infections.
    Lam KM; Lin W; Yamamoto R; Ghazikhanian GY
    Isr J Med Sci; 1984 Oct; 20(10):992-4. PubMed ID: 6511327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.